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The formation, maintenance, and repair of epithelial barriers are of critical importance for whole-body homeostasis. However,
the molecular events involved in epithelial tissue maturation are not fully established. To this end, we investigated the molecular
processes involved in renal epithelial proximal-tubule monolayer maturation utilizing transcriptomic, metabolomic, and func-
tional parameters. We uncovered profound dynamic alterations in transcriptional regulation, energy metabolism, and nutrient
utilization over the maturation process. Proliferating cells exhibited high glycolytic rates and high transcript levels for fatty acid
synthesis genes (FASN), whereas matured cells had low glycolytic rates, increased oxidative capacity, and preferentially ex-
pressed genes for beta oxidation. There were dynamic alterations in the expression and localization of several adherens (CDH1,
-4, and -16) and tight junction (TJP3 and CLDN2 and -10) proteins. Genes involved in differentiated proximal-tubule function,
cilium biogenesis (BBS1), and transport (ATP1A1 and ATP1B1) exhibited increased expression during epithelial maturation.
Using TransAM transcription factor activity assays, we could demonstrate that p53 and FOXO1 were highly active in matured
cells, whereas HIF1A and c-MYC were highly active in proliferating cells. The data presented here will be invaluable in the fur-
ther delineation of the complex dynamic cellular processes involved in epithelial cell regulation.
The primary function of epithelial cells is to form a selectivebarrier between two adjacent compartments. However, epi-
thelial cells are not merely barriers but possess many other func-
tions qualifying them as one of the most diverse group of cells in
the human body. Epithelial cells can be considered the body’s
regulators, functioning in concert to allow precise homeostatic
regulation. The loss of regulated epithelial function gives rise to
many disease states, including chronic inflammation, fibrosis
(leading to end-stage organ failure), and cancer. Indeed, the vast
majority of all diagnosed cancers are of epithelial origin (termed
carcinomas). In recent years, the use of epithelial cell cultures has
allowed detailed studies of many cellular and molecular aspects of
epithelial cell physiology and pathophysiology.
In the kidney alone, more than 12 morphologically distinct
types of epithelial cells have been described (1). The proximal
tubule is the main site of reabsorption in the nephron and is con-
sidered a “leaky” epithelium due to the expression of pore-form-
ing claudins 2 and 10 in the tight junctions (2). The high transport
rates of the proximal tubule are driven primarily by the Na/K
ATPase, creating a high energy demand that is predominantly
fulfilled by oxidative metabolism (3). In addition, this part of the
nephron is one of the areas most sensitive to chemical and isch-
emic injury (4–6).
The formation, maintenance, and repair of epithelial barriers
are of critical importance for the maintenance of whole-body ho-
meostasis and thus are very tightly regulated processes. Generally,
the processes involved in epithelial proliferation are the opposite
of those required for cell differentiation (7). Both states involve
the sensing of the external environment, providing the cell with
critical information pertaining to orientation, neighboring cells,
and tissue density. These signals are relayed to the nucleus to ac-
tivate transcription and alter processes involved in energy metab-
olism (8), differentiated function (7), proliferation (9), and mo-
tility (10). Tight and adherens junctions exert central control in
the regulation of cell-to-cell contact and tissue density (11, 12). A
low number of intercellular interactions favors epithelial cell pro-
liferation, whereas a high density of intercellular contacts halts
proliferation and promotes differentiation, allowing the establish-
ment of specific tissue functions.
The transition of epithelial cells from proliferating, highly en-
ergy-consuming cells to a mature transporting epithelium is com-
plex, involving the simultaneous activation and inactivation of
several distinct pathways. In order to characterize these processes
at a molecular level, we used a simple cell culture system where
renal epithelial cells were seeded at low density in culture dishes.
Primary human proximal-tubule cells and a telomerase-immor-
talized human proximal-tubule cell line (RPTEC/TERT1) were
studied over a maturation process of 16 days. Transcriptomics and
metabolomics were used to investigate the processes involved in
epithelial monolayer maturation.
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All chemicals were purchased from Sigma-Aldrich unless otherwise
stated.
Cell culture. Human primary proximal-tubule cells were prepared as
previously described (13). Both primary and RPTEC/TERT1 (14) cells
were cultured in hormonally defined medium that consisted of a 1:1 mix-
ture of Dulbecco’s modified Eagle’s medium (DMEM; catalog no. 11966;
Invitrogen) and Ham’s F-12 nutrient mix (catalog no. 21765; Invitrogen)
supplemented with 2 mM Glutamax (Invitrogen), 5 g/ml insulin, 5
g/ml transferrin, 5 ng/ml sodium selenite, 100 U/ml penicillin, 100
g/ml streptomycin, 10 ng/ml epithelial growth factor, and 36 ng/ml hy-
drocortisone. Routinely, cells were cultured in 10-cm dishes (Sarstedt) at
37°C in a 5% CO2 humidified atmosphere and subcultured by trypsiniza-
tion. Medium was replaced three times per week, and the volumes were 2
ml for 6 wells, 10 ml for 10-cm dishes, and 1 ml for coverslips. RPTEC/
TERT1 cells were used at passages 76 to 100. Primary cells were used at
passage 3.
For studying epithelial monolayer formation, cells were freshly seeded
to a density of 30% surface area and followed over the following 16-day
interval. Medium was replaced every day.
Transcriptomic and array analysis. Cells were cultured on 6-well
plates, and RNA was isolated by cell lysis in RLT buffer (Qiagen) contain-
ing 1% (vol/vol) -mercaptoethanol and further processed with a Qiagen
RNeasy Protect cell minikit. For the synthesis of biotinylated cRNA, a
MessageAmp II aRNA amplification kit (Ambion Inc.) with several mod-
ifications (15) was applied using the Theonyx automatic pipetting robot
(Aviso GmbH). To optimize the cleanup, the Agencourt RNAClean
(Beckman Coulter) method was used instead of a column-based method.
RNA quality was controlled using a 28S/18S ratio with an Agilent Bioana-
lyzer 2100, and the RNA quantity was assessed with a NanoDrop (Thermo
Fisher Scientific) ND-1000 photometer before processing. Amplified
biotin-labeled cRNA (750 ng) was hybridized in a hybridization chamber
for 20 h at 58°C on Illumina human HT12 v3 BeadChips, which assay
48,802 probes per sample. Afterwards, the chips were washed and stained
with 1 g/ml streptavidin-conjugated Cy3 (Amersham Biosciences).
Chips were then dried by centrifugation, and fluorescence was detected by
confocal laser scanning with an Illumina bead array reader (Illumina) at
532 nm and a 0.8-m resolution. Using Illumina BeadStudio software, the
data from all beads with the same probe were condensed to one value and
further to ensure array quality based on different control bead parameters.
Quantile normalization was applied to remove nonbiological variance
between arrays (16).
Selection of significantly deregulated genes and cluster analysis of the
unsupervised samples were performed using BRB ArrayTools (version 4)
(17). Hierarchical clustering of samples using centered correlation and
average linkage was carried out, and samples demonstrating a correlation
lower than 0.5 to their biological replicates were considered outliers and
excluded from further analysis (three primary-cell samples). A class com-
parison was conducted between all time points within each cell model
with a cutoff of 1.5-fold change and a significance level for P of 0.001 for
the univariate test. The log2 fold change value of the differentially ex-
pressed probes (DEP) is represented here as the ratio of the value at the
later time point to that at the earlier time point. DEPs from the RPTEC/
TERT1 and primary-cell data sets were intersected according to direction
of change. Thus, only DEPs that changed in the same direction in both cell
models were used for further analysis. The combined list (1,630 DEPs)
was then subjected to a time course analysis in BRB ArrayTools with a
threshold false discovery rate of 0.01. The expression values of the result-
ing 1390 DEPs were normalized by “mean centering” (expression values
of each probe were divided by the mean expression of that probe over all
time points within each cell model). Heat maps were generated us-
ing TreeView (http://rana.lbl.gov/EisenSoftware.htm). Where multiple
probes existed for the same gene, the probe with the highest variance
across the RPTEC/TERT1 time course was chosen. Finally, a list of 1,238
differently expressed genes (DEG) reflecting gene alterations during the
time course of monolayer formation was generated.
Quantitative real-time PCR (qPCR). At 1, 7, and 16 days after seed-
ing, RNA was harvested from RPTEC/TERT1 cells on 10-cm dishes as
described above. cDNA was synthesized from 500 ng of total RNA using a
Dynamo cDNA synthesis kit (Biozyme). qPCRs were performed using 5
HOT FIREPol EvaGreen qPCR Mix Plus (Medibena) on a Rotor-Gene Q
(Qiagen) according to the manufacturer’s protocol. Three biological sam-
ples were analyzed with 4 technical replicates each. A standard curve was
generated using a dilution series of a reference RPTEC/TERT1 sample.
Primer pairs used for amplification of the target genes are given in Table 1.
Transcription factor (TF) prediction analysis. The complete list of
1,390 DEPs and their mean-centered expression values were uploaded
into Ingenuity Pathway Analysis (IPA) version 9.0 (1,353 mapped genes;
in cases of multiple probes for one gene, the probe with the maximum
absolute log2 ratio was used, and for prediction of TF activation, direct
and indirect relationships were considered where confidence at an exper-
imental level was available), which includes a TF analysis feature. TF anal-
ysis computes an overlap P value (Fisher’s exact test) assessing whether
there is a statistically significant overlap between the genes in the data set
and the genes that are regulated by a TF. The activation state of the TF is
predicted by a second parameter, the z score, that reflects the expected
causal effects between a TF and its targets based on the expression direc-
tion of the genes in the data set regulated by the given TF. A z score greater
than 2 predicts significant activation and a score lower than 2 points to
an inhibition of the given TF. For the refined selection of TFs, only TFs
with an overlap P value of 0.001, a z score of 2 or 2 at least at one
time point in both cell models and more than 10 altered target molecules
were considered.
Transcription factor activity assays. Nuclear extracts from RPTEC/
TERT1 cells cultured in 10-cm dishes at 1 day (subconfluent) and 16 days
(matured) after seeding were washed and scraped into ice-cold hypotonic
buffer [10 mM HEPES-NaOH, pH 7.9, containing 10 mM KCl, 0.1 mM
EDTA, 0.1 mM EGTA, 1 mM dithiothreitol (DTT), 1 mM phenylmeth-
ylsulfonyl fluoride (PMSF), protease inhibitor cocktail (catalog no.
P8340; Sigma), phosphatase inhibitor cocktail (catalog no. P0044; Sigma),
and 2 mM activated Na3VO4]. The cell suspensions were incubated for 20
min on ice, and then 10% (vol/vol; final concentration, 0.58%) Igepal
CA-630 was added to lyse the cells. Samples were centrifuged at 21,000 
g for 1 min, and the resulting pellets were resuspended in high-salt buffer
[20 mM HEPES-NaOH, pH 7.9, containing 400 mM NaCl, 1 mM EDTA,
1 mM EGTA, 10% (vol/vol) glycerol, 1 mM DTT, 1 mM PMSF, protease
inhibitor cocktail, phosphatase inhibitor cocktail and 2 mM activated
Na3VO4]. Samples were incubated for 30 min on ice with periodic vor-
texing and were subsequently centrifuged at 21,000  g for 10 min at 4°C.
The resulting supernatants were removed as the nuclear extracts. The
protein content of nuclear extracts of RPTEC/TERT1 cells was measured
using the bicinchoninic acid (BCA) method according to the manufactur-
er’s protocol (Pierce, Thermo Scientific). For the assays of TP53, FOXO1,
and c-MYC, 20 g nuclear extract per well was used, and for HIF1A, 30 g
nuclear extract per well was used. Levels of transcriptionally active TP53,
HIF1A, FOXO1, and c-MYC were determined by using TransAM tran-
scription factor enzyme-linked immunosorbent assays (ELISAs) (Active
Motif) according to the manufacturer’s protocol.
TABLE 1 qPCR primer sequences
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Cell cycle analysis. At indicated time points, RPTEC/TERT1 cells cul-
tured on 6-well plates, were washed twice in phosphate-buffered saline
(PBS) and harvested using 1 ml phenol red-free 5% (wt/vol) trypsin–2%
(wt/vol) EDTA solution per well after prolonged incubation at 37°C. Cell
pellets were washed three times with ice-cold PBS and fixed in 100%
ice-cold methanol. The fixed cells were stored at 4°C until analysis. On the
day of analysis, cells were washed thrice with ice-cold PBS and stained
with propidium iodide (PI)-RNase staining buffer (5 g/ml PI, 200 g/ml
RNase) (Becton, Dickinson Biosciences). Cell cycle distribution was as-
sessed using a Becton, Dickinson FACScan (Becton, Dickinson Biosci-
ences) and BD Cell Quest Pro 4.0.2 software (25 000 positive hits, custom
inclusion criteria). The data were then analyzed using BD ModFit.
Glycolysis and glycogen measurements. Lactate was measured in the
supernatant medium with a colorimetric assay, as previously described
(18). Glucose was measured in the supernatant medium from the same
samples using a colorimetric hexokinase-based assay, as previously de-
scribed (19). Glycogen was measured in methanol extracts by boiling the
insoluble fractions in 0.03 N HCl, followed by addition of 10 mM sodium
acetate (pH 4.9), incubation of samples with or without amyloglucosidase
(24 U/ml, from Aspergillus niger; catalog no. 10115; Sigma), and subse-
quent determination of glucose. Glycogen content was calculated as the
difference between glucose levels with and without amyloglucosidase con-
version.
1H nuclear magnetic resonance (NMR) spectroscopy and metabolic
profile data processing. For 1H NMR spectroscopy, 1 ml of cell culture
medium (supernatant) was centrifuged for 5 min at 150  g to remove
dead cells and subsequently stored at 80°C to await NMR analysis. 1H
NMR spectroscopy and data processing for metabolomic investigation
were performed as described by Ellis et al. (20). Briefly, to 550 l super-
natant, 50 l of D2O [containing 0.2% (wt/vol) TSP (trimethylsilyl pro-
pionate] was added, vortexed, and then centrifuged (13,000  g, 10 min)
to remove insoluble material before the mixture was transferred to a clean
NMR tube. All reagents were checked prior to sample preparation by
obtaining a one-dimensional 1H NMR spectrum to ensure that they con-
tained no contaminants that may interfere with the downstream spectro-
scopic analysis. CPMG (Carr-Purcell-Meiboom-Gill) spectra were ac-
quired on a 600-MHz Bruker spectrometer for each sample to suppress
broad protein peaks. NMR spectroscopic data were imported and manip-
ulated in Matlab (Mathworks) using in-house software written and com-
piled by T. M. D. Ebbels, H. C. Keun, J. T. Pearce, and R. Cavill. Using this
software, the 1H NMR spectra were automatically phased, baseline cor-
rected, and referenced and normalized to the TSP resonance at  0.
Immunofluorescence analysis. RPTEC/TERT1 cells were cultured on
18-mm glass coverslips in 24-well plates and fixed in 100% ice-cold meth-
anol for 10 min at 20°C at three states: subconfluent, newly confluent,
and as a matured monolayer. Fixed cells were incubated at room temper-
ature in blocking buffer (5% [wt/vol] bovine serum albumin [BSA; Cal-
biochem, Merck], 1% [vol/vol] Triton X-100 in PBS) for 30 min followed
by incubation with primary antibody for 1 h. All antibodies were diluted
in antibody diluent in a 1% BSA, 0.2% Triton X-100 PBS solution. Mouse
anti-E-cadherin (no. 610182; BD Transduction Laboratories) was used at
0.31 g/ml, rabbit anti-cadherin 4 (HPA015613; Sigma) at 0.44 g/ml,
rabbit anti-cadherin 16 (Abcam, ab80320) at 10 g/ml, mouse anti-clau-
din 2 (no. 32-5600; Invitrogen) at 1.6 g/ml, rabbit anti-claudin 3
(SAB4500435; Sigma) at 2 g/ml, rabbit anti-claudin 10 (ab52234; Ab-
cam) at 3.3 g/ml and rabbit anti-ZO3 (no. 36-4000; Zymed, Invitrogen)
at 1.25 g/ml. Cells were incubated with 2.5 g/ml of the appropriate
Alexa 488-conjugated secondary antibody (no. A11059 and A21206; In-
vitrogen) for 35 min. Repeated washing with PBS was performed between
the incubation steps. Cells were mounted in 3 mg/ml p-phenylene-di-
amine glycerol on a microscope slide and sealed with nail varnish. Fluo-
rescence images were obtained using a Zeiss Axiophot fluorescence mi-
croscope mounted with a 63 oil immersion objective (1.4 numerical
aperture; Zeiss). Images were captured with a cooled charge-coupled de-
vice (CCD) camera (Spot Diagnostics) using Metavue image processing
software (Molecular Devices).
Western blot analysis. RPTEC/TERT1 cells were lysed in RIPA buffer
including protease inhibitor cocktail (catalog no. 8340; Sigma) and 10
l/ml phosphatase inhibitor (catalog no. P0044; Sigma) at various time
points. Samples were incubated for 30 min on ice and then centrifuged at
8,000  g for 5 min to separate RIPA buffer-soluble and -insoluble frac-
tions. Protein concentrations of the soluble fraction samples were deter-
mined by the BCA method according to the manufacturer’s protocol
(Pierce). The insoluble fraction was resuspended directly in 90 l Laem-
mli buffer. Soluble (35 to 40 g total protein in Laemmli buffer) and
insoluble (15 l of the resuspended pellet) samples were run on 4 to 12%
bis-Tris minigels (Invitrogen). Gels for blots of proteins of 40 kDa were
run in NuPage MES (morpholineethanesulfonic acid) SDS running buffer
and those of proteins of 40 kDa in NuPage MOPS (morpholinepro-
panesulfonic acid) SDS running buffer (Invitrogen) at 200 V for 35 min
and 50 min, respectively. Proteins were transferred onto methanol-acti-
vated low-fluorescence Immobilon-P membranes (Millipore, Merck) in
2 NuPage transfer buffer (Invitrogen) containing 20% methanol (for
proteins of 40 kDa) or 10% methanol (for proteins of 40 to 110 kDa) for
30 or 60 min, respectively (maximum, 20 V) using a semidry transfer
system (Invitrogen). Membranes were blocked in 5% (wt/vol) BSA (Cal-
biochem)–Tris-buffered saline-Tween (TBST) for 1 h and probed with
primary antibodies (2 h at room temperature [RT] or overnight at 4°C).
All antibodies were diluted in TBST, except for anti-cadherin 4, anti-
cadherin 16, and anti-ZO3, which were diluted in 5% BSA-TBST. Mouse
anti-E-cadherin (no. 610182; BD Transduction) was used at 0.1 g/ml,
rabbit anti-cadherin 4 (HPA015613; Sigma) at 0.44 g/ml, rabbit anti-
cadherin 16 (ab80320; Abcam) at 1 g/ml, mouse anti-claudin 2 (no.
32-5600; Invitrogen) at 0.8 g/ml, rabbit anti-claudin 3 (SAB4500435;
Sigma) at 2 g/ml, rabbit anti-claudin 10 (ab52234; Abcam) at 2 g/ml,
and rabbit anti-ZO3 (no. 36-4000; Zymed, Invitrogen) at 2.5 g/ml.
Mouse anti-beta actin (no. A2228; Sigma) at 0.1 g/ml was used as an
internal control. Blots were incubated with the appropriate secondary
antibody conjugated to Cy3 or Cy5 (1:5,000; no. PA45011V and
PA443009V; GE Healthcare) for 1 h at RT. Bands were detected using an
Image Quant Las 4000 imager (GE Healthcare) and visualized and quan-
tified with Image Quant TL image analysis software (GE Healthcare). For
graphical representation, target values were normalized to the respective
beta-actin band and expressed as the increase (fold) over maximum in-
tensity.
Oxygen consumption analysis. Oxygen was measured using oxygen
sensor spots (PreSens) mounted on the inside of the upper lid of 10-cm
dishes, connected on the outside to the accompanying fiber optic AD
system Fibox 3 (PreSens). One hour before initiation of measurement,
medium was renewed and equilibrated to 21% oxygen and 37°C in a 5%
CO2 humidified atmosphere. Dishes were sealed with PetriSeal adhesive
tape, and oxygen in the headspace was measured over a 15-min period at
3, 6, and 24 h after sealing. The measurement cycle was repeated every
second day from day 1 to day 18 after seeding. Oxygen consumption was
determined using an exponential decline fitting for greatest correlation
and then integrated for the area over the curve (AOC). To adjust for cell
number, 10 or more randomly spaced microscope images per dish were
taken with a Zeiss Axiovert 100 microscope at a magnification of 320
before and after each measurement cycle, and cells were counted in an
area of 0.08 mm2 using the Image J cell counting tool (National Institutes
of Health). Average total cell number of a 10-cm dish was then calculated
at the respective time points.
In addition, oxygen consumption measurements were performed in
the presence of a 10 M concentration of the oxidative phosphorylation
uncoupler carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone
(FCCP) in order to elucidate the maximum oxygen consumption capac-
ity. Measurements were conducted as described above for a maximum of
8 h. FCCP treatment was conducted in three states: subconfluent (day 1),
newly confluent (day 6), and matured (days 25 to 30).
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Stereology. Total RPTEC/TERT1 cell volume was estimated by a ste-
reology approach using light and electron microscopy, as previously de-
scribed in detail (21). Briefly, newly confluent and matured RPTEC/
TERT1 cells were washed with PBS, fixed in 1% (vol/vol) glutaraldehyde,
and then postfixed in 1% (wt/vol) OsO4. Monolayers were dehydrated
and embedded in Polybed (Polysciences) for transmission electron mi-
croscopy (TEM). Relative volume values (VV) of nuclei, mitochondria,
and other subcellular structures (e.g., agglomerates of glycogen) were es-
timated at a magnification of 5,000 by point counting (22) utilizing a
square lattice and the relationship Vv 	 Pi/Pr  d, where Pi is the number
of lattice cross points overlying the structure of interest i, Pr is the total
number of lattice cross points over the reference structure r, and d is the
lattice square length. Absolute values can be obtained by referring the
relative values to the mean average cell volume of RPTEC/TERT1 cells.
The latter value was obtained from the number of cells per unit area of
culture dish and the mean thickness of the monolayer assessed from elec-
tron micrographs of strictly perpendicularly cut cell monolayers.
Statistics. Statistical tests were applied to data in GraphPad Prism 5.02
and are specified in the legends. The error bars in the figures represent
standard deviation (SD), and the n values are given in the legends.
RESULTS
Cells transition from mesenchymal to cobblestone epithelial
morphology during the maturation process. Phase-contrast im-
ages at different times of monolayer maturation showed that both
primary and RPTEC/TERT1 cells matured from spindle-shaped
subconfluent cells to cobblestone-shaped epithelial cells (Fig. 1).
In addition, both cell types developed extensive dome formation
at the later time points that are indicative of unidirectional trans-
port of water and solutes and thus of a matured epithelium.
The number of transcriptomic alterations decreased over the
time course of the experiment. At 3-day intervals over the 16-day
monolayer maturation process, RNA was harvested for whole-
genome microarray analysis. Hierarchical clustering of the unsu-
pervised samples revealed a high correlation (0.5) among the
time-matched replicates (Fig. 2A). RPTEC/TERT1 and primary
cells clustered separately from each other. In both cell types, two
time-dependent clusters appeared (correlation  0.4), grouping
early time points (days 1 and 4) away from later time points (days
7 to 16) (Fig. 2A). Class comparisons (1.5-fold change; P  0.001)
conducted between two time points uncovered a decreasing num-
ber of differentially expressed probes (DEPs) over the time of
monolayer maturation, indicating a stabilization of the transcrip-
tome as the monolayer matured (Fig. 2B).
Adherens junction proteins mediating cell adhesion in-
creased during epithelial maturation, whereas those that sup-
port cell migration decreased. Since adherens junction (AJ) pro-
teins are key players in mediating cell-cell contacts (23), we
FIG 1 Morphology of RPTEC/TERT1 (A) and primary cells (B) over the experimental time course. Phase-contrast images were captured at the indicated time points
after seeding. Domes are visible as structures that are out of focus. Micrographs were obtained with a Zeiss Axiovert 100 microscope at a magnification of 320.
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investigated the protein expression and localization of cadherins
that were altered in the transcriptomic data. mRNA levels for cad-
herin 1 (encoded by CDH1; also known as E-cadherin) increased,
whereas levels of the cadherin 4 gene (CDH4) decreased over time,
exhibiting the highest expression on days 1 and 4 (Fig. 3A). Cad-
herin 16 (CDH16) mRNA and protein levels were highest at inter-
mediate time points. CDH1 exhibited increased junctional target-
ing and abundance during maturation, whereas the opposite was
true for CDH4 (Fig. 3A). CDH16, on the other hand, exhibited
maximal junctional expression at confluence and became more
diffuse after monolayer maturation (Fig. 3A). In the matured ep-
ithelium, CDH16 was junctionally expressed in a very small subset
of the population which corresponded to cells at the apex of some
domes (Fig. 3A).
Tissue-specific tight junction proteins exhibited enhanced
expression in the matured monolayer. The tight junction (TJ)
complex is one of the main regulators of cell density and contact
inhibition (24) and also plays a role in the maintenance and reg-
ulation of the epithelial barrier. The transcript levels of genes for
the TJ proteins claudin (CLDN-2, -3, and -10) and tight junction
protein 3 (TJP3; also known as ZO3) increased over the time
course (Fig. 3B). A similar expression pattern was observed at
protein level (Fig. 3B). Additionally, CLDN2, -3, and -10 exhibited
increased junctional expression over the maturation period. TJP3
exhibited predominant nuclear expression in proliferating cells
but was exclusively junctionally expressed after confluence was
reached (Fig. 3B). Additionally, TJP3 increased in protein abun-
dance over the maturation period.
Transcriptome alterations associated with arrest in G0/G1
cell cycle phase. As expected, a large number of the differentially
expressed genes are associated with cell cycle (Fig. 4A). For the
most part, the expression levels of these genes were higher at early
time points (day 1 and 4) and lower at the later time points (day 7
to 16). Many of the G1/S-phase genes exhibited the opposite ex-
pression pattern, however. This was observed for B-cell transloca-
tion gene 1, anti-proliferative (BTG1), cyclin-dependent kinase in-
hibitor 1B (CDKN1B, encoding a protein also known as p27),
cyclin G2 (CCNG2), inhibitor of growth family, member 4 (ING4),
CDC14 cell division cycle 14 homolog B (CDC14B), lysine (K)-spe-
cific demethylase 5B (JARID1B), leucine zipper, putative tumor sup-
pressor 1 (LZTS1), polo-like kinase 1 substrate 1 (C20ORF19, en-
coding a protein also known as PLK1S1), cell cycle progression 1
(CCPG1), and kelch-like 9 (KLHL9).
The gene expression pattern of these cell cycle-associated genes
points to a highly proliferating status until day 4, followed by
arrest in the G0/G1 phase. This was confirmed by cell cycle analysis
using flow cytometry (Fig. 4B), which indicated that at a subcon-
fluent state (day 1), 53.8% (
8.0%) of the cells were in G0/G1
phase, 33.3% (
5.0%) in S phase and 12.8% (
4.9%) in G2/M
phase. Cell cycle distribution was similar on day 3 and shifted at
day 5, with most cells being in G0/G1 phase (84.5% 
 0.7%),
whereas the fractions in S phase (11.8% 
 0.7%) and G2/M phase
FIG 2 Overview of gene alterations over monolayer formation. (A) Hierarchical clustering. Dendrogram of the hierarchical clustering (centered correlation and
average linkage) of the unsupervised samples. The dashed line indicates a correlation of 0.5. Samples that had a correlation of 0.5 with their biological replicates
were excluded from further analysis (n 	 3). (B) Matrix showing the number of delta differentially expressed probes (DEP) (1.5-fold change; P  0.001) between
two time points for each cell model. Dark and light gray boxes indicate the numbers of DEPs for RPTEC/TERT1 and primary cells, respectively.
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 0.8%) were decreased. This trend continued until day 18,
where 96.4% (
0.6%) of the cells were in G0/G1 phase, 1.8%
(
0.3%) were in S phase, and 1.8% (
0.7%) were in G2/M phase.
During the maturation process, cells switch from a highly
glycolytic and oxygen-consuming metabolism to predomi-
nately oxidative metabolism and beta-oxidation of fatty acids. A
number of genes involved in energy metabolism (glycolysis, tri-
carboxylic acid [TCA] cycle, oxidative phosphorylation, redox
regulation, and fatty acid metabolism) exhibited altered expres-
sion during monolayer maturation (Fig. 5A). Two main expres-
sion patterns could be distinguished: a peak expression at early
time points (day 1 to 4) and a peak expression at intermediate time
points (day 7 to 10). Early highly expressed genes comprised those
involved in fatty acid synthesis, including solute carrier family 25,
member 1 (SLC25A1) and fatty acid synthase (FASN), as well as
genes implicated in redox regulation, such as thioredoxin (TXN),
thioredoxin reductase (TXNRD1), sulfiredoxin 1 homolog (SRXN1),
glutathione S-transferase omega 1 (GSTO1), and gamma-glutamyl-
cyclotransferase (GGCT). Two genes encoding members of the less
well characterized class 3 glucose transporters, SLC2A6 and
SCL2A12 (also known as GLUT6 and 12), exhibited the highest
expression levels on day 1 and 4, respectively. Genes involved in
redox regulation displayed the highest expression at intermediate
time points and included catalase (CAT), glutathione S-transferase
alpha 4 (GSTA4), mu 1 (GSTM1), thioredoxin interacting protein
(TXNIP), and NAD(P)H dehydrogenase, quinone 1 (NQO1).
Genes involved in glycolysis and TCA cycle also demonstrated
peak expression at intermediate time points and comprised lactate
dehydrogenase B (LDHB), pyruvate dehydrogenase (lipoamide)
alpha 1 (PDHA1), and oxoglutarate dehydrogenase-like (OGDHL)
as well as genes implicated in the beta-oxidation of fatty acids,
such as butyrobetaine (gamma), 2-oxoglutarate dioxygenase 1
(BBOX1), acyl-coenzyme A synthetase medium-chain family
member 3 (ACSM3), short-chain family member 1 (ACSS1), and
solute carrier family 25 and member 29 (SLC25A29). Additionally,
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB)
isoforms, responsible for the synthesis and degradation of fruc-
tose-2,6-bisphosphate, displayed an altered expression profile:
PFKFB3 was decreased in proliferating cells, whereas PFKFB4 was
increased.
NMR profiling of supernatant medium in proliferating and
matured RPTEC/TERT1 cells demonstrated a decreased utiliza-
tion of glutamine, tyrosine, valine, isoleucine, and glucose in the
matured epithelium (Fig. 5B). The glutamine and alanine profiles
are of particular interest, since the utilization of both spiked at 24
h, most likely due to catabolism of the medium supplement L-al-
anyl-L-glutamine (Glutamax, 2 mM). Membrane-bound amino-
peptidases hydrolyze the dipeptide, releasing alanine and glu-
tamine into the culture medium. Alanine did not seem to be
further used by the cells when they were either proliferating or
matured, but glutamine was consumed faster in proliferating cells.
Additionally, there was a decreased rate of production of oxo-
isovalerate, oxo-methylisovalerate, formate, and lactate in the ma-
tured epithelium. In order to compare the kinetics of glycolysis
between these two states, we measured lactate and glucose in the
supernatant medium over the maturation process with biochem-
ical assays. Glucose utilization and lactate production steadily de-
creased over the time course and reached a steady state at day 8
(Fig. 5C).
We originally hypothesized that this glycolytic switch would be
paralleled by a switch to oxidative metabolism. However, oxygen
consumption measurements revealed that proliferating cells con-
sumed significantly more oxygen than the matured epithelium
(Fig. 5D). To examine further the respiration states at different
time points after seeding, we applied the uncoupler FCCP, which
disrupts the proton gradient across the mitochondrial inner mem-
brane. This causes an increase in the intracellular concentration of
ADP stimulating the transfer of electrons to oxygen molecules
(25). FCCP treatment can thus be used to measure the capacity of
the electron transfer system. Proliferating cells and newly conflu-
ent cells showed no altered respiration with FCCP compared to
their time-matched control (Fig. 5E), whereas FCCP treatment of
matured monolayers resulted in a significantly higher rate of ox-
ygen consumption than was seen in time-matched control and
proliferating cells (Fig. 5E). Inhibition of complex III of the elec-
tron transfer chain by antimycin A caused a small increase in lac-
tate production in proliferating cells, whereas nonproliferating
cells reverted to a highly glycolytic metabolism (Fig. 5F). Stereo-
logical analysis of matured cells demonstrated a 2.5-fold decrease
in cell volume (Fig. 5H, inset) paralleled by a slight, although not
significant, increase in mitochondrial volume (Fig. 5H). In line
with this trend is the observation that peroxisome proliferator-
activated receptor gamma, coactivator 1 alpha (PPARGC1A), a gene
involved in mitochondrial biogenesis, exhibited increased expres-
sion in matured cells (Fig. 5A). A trend pointing to a reduction in
glycogen stores was also observed in matured cells by stereological
analysis (Fig. 5H). Biochemical measurement of glycogen revealed
the highest glycogen storage after the most intense aerobic glycol-
ysis phase, which declined afterwards to basal levels (Fig. 5G).
During this peak, the gene encoding the glycogen-degrading en-
zyme glycogen phosphorylase, brain (PYGB), was highly ex-
pressed (Fig. 5A).
Taken together, these data suggest that proliferating cells run
both oxidative and glycolytic metabolism at full capacity (Fig. 5C
to E), while matured cells exhibit lower energy requirements but
have a higher capacity for oxidative metabolism. Furthermore,
disruption of oxidative phosphorylation with antimycin A reacti-
vates glycolysis in matured monolayers (Fig. 5F).
Genes associated with transport, proximal-tubule differen-
tiation, and ciliogenesis were increased in the matured epithe-
lium. The proximal tubule is the main site in the nephron for
solute and nutrient reabsorption. Interestingly, the transcript lev-
els of genes encoding three subunits of the Na/K ATPase
(ATP1A1, ATP1B1, and FXYD2), which is the driving force for
FIG 3 Adherens (A) and tight (B) junction protein expression during monolayer formation and maturation. (Top) Heat maps of adherens junction (AJ) and tight
junction (TJ) protein genes. Average mean-centered mRNA expression values (log2) per time point and cell type were used to generate the heat maps. Cell colors reflect
the value and direction of the expression value relative to the mean expression over all time points (red indicates higher expression and green indicates lower expression
compared to the mean) (n 	 3). (Bottom) Immunofluorescence staining and Western blots including band intensity quantification (RIPA buffer-soluble and -insoluble
fractions; minimum n 	 4) of AJ and TJ proteins in RPTEC/TERT1 cells at different time points after seeding. Band intensities were normalized first to actin and then
to the maximum intensity per replicate. Values are means plus SD; statistical significances of changes in Western blot band intensities at day 16 were analyzed using
one-way analysis of variance (ANOVA) with the Bonferroni multiple comparison test post hoc. *, P  0.05; **, P  0.01; ***, P  0.001.
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transport processes in the proximal tubule, increased over time,
whereas subunit FXYD5, associated with decreased cell adhesive-
ness (26), showed the opposite expression profile (Fig. 6). Several
members of the ATP-binding cassette transporter family and
solute carrier family exhibited altered expression over the time
course. Expression of several genes involved in important
proximal-tubular functions, including serine carboxypeptidase 1
(SCPEP1) (27) and parathyroid hormone 1 receptor (PTHR1) (14),
were increased during the maturation process, whereas expression
of a few also decreased, for example, alanyl (membrane) amino-
FIG 4 Cell cycle alterations over monolayer formation and maturation. (A) Heat map of cell cycle genes identified in the DEG list. Genes were assigned to G0/G1,
G1/S, S, S/G2, G2/M, or M phase of the cell cycle and then ranked within a cell cycle phase according to the difference between day 1 and 16 values in the
RPTEC/TERT1 data set. Average mean-centered mRNA expression values (log2) per time point and cell type were used to generate the heat map. Cell colors reflect the
expression value and direction relative to the mean expression over all time points (red indicates higher expression and green indicates lower expression compared to the
mean) (n 	 3). (B) Cell cycle distribution of RPTEC/TERT1 cells at different time points after seeding. Values are means 
 SD; statistical significance of changes
compared to day 1 was analyzed using two-way ANOVA with the Bonferroni multiple comparison test post hoc. *, P  0.05; **, P  0.01; ***, P  0.001 (n 	 3 to 6).
Aschauer et al.














































FIG 5 Alterations in energy metabolism and mitochondrial function over monolayer formation and maturation. (A) Heat map of energy metabolism-
associated genes. Genes are grouped according to their function in different metabolic pathways and then ranked within the group to the difference
between day 1 and 16 values in the RPTEC/TERT1 data set. Average mean-centered mRNA expression values (log2) per time point and cell type are
represented in red (higher expression compared to the mean) and green (lower expression compared to the mean) (n 	 3). (B) Metabolic alterations
measured by NMR in RPTEC/TERT1 supernatant. Values are minima and maxima, in percent, normalized per metabolite. Colors represent abundances
of the respective metabolites, where red indicates high abundance and green indicates low abundance (n 	 3). (C) Lactate production and glucose
consumption rates over RPTEC/TERT1 maturation time. n 	 3. (D) Oxygen consumption rate over RPTEC/TERT1 maturation time. Statistical
significance was analyzed using one-way ANOVA with the Bonferroni multiple comparison test post hoc (n 	 3). (E) Oxygen consumption of RPTEC/
TERT1 cells after treatment with oxidative uncoupler FCCP for 8 h. Two-way ANOVA with the Bonferroni multiple comparison test post hoc was used to
analyze statistical significance (n 	 3). (F) Lactate production of RPTEC/TERT1 cells after treatment with the electron transfer chain complex III inhibitor
antimycin A for 8 h. Statistical significance was analyzed using one-way ANOVA with the Bonferroni multiple comparison test post hoc to time-matched
control (n 	 3). (G) Glycogen storage at different time points after seeding (n 	 3). (H) Relative volume of RPTEC/TERT1 cell fractions, as determined
by stereology. Insert depicts the calculated absolute volume of newly confluent and matured cells. Statistical significance was analyzed by applying a
two-tailed unpaired t test. P values are indicated above the bars (n 	 3). (B to H) Experiments were performed with RPTEC/TERT1 cells. (C to H) Values
are means 
 SD. *, P  0.05; **, P  0.01; ***, P  0.001. PPP, pentose phosphate pathway.
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peptidase (ANPEP) (Fig. 6). We also identified an augmentation in
the expression of several genes implicated in cilium biogenesis and
maintenance, including dynein, cytoplasmic 2, light intermediate
chain 1 (DYNC2LI1), Bardet-Biedl syndrome 1 and 12 (BBS1,
BBS12), intraflagellar transport 57 homolog (IFT57), and primary
ciliary dyskinesia protein 1 (PCDP1) (Fig. 6).
Identification of transcription factor master regulators of
proliferation and maturation. The list of differentially expressed
probes over the time course was subjected to transcription factor
(TF) analysis in IPA. The refined analysis yielded 9 TFs with pre-
dicted early activation, 12 activated at later time points, and 1
(JUN) that was activated at both times (Fig. 7). Among the early
active TFs were TBX2, FOXM1, MYC, HIF1A, and E2F1-3, and
among the later active TFs, TP53, CDKN2A, RB1, KDM5B, and
FOXO3 were identified.
From four TFs of the list of predicted TFs activity-ELISAs were
performed. These assays confirmed that TP53 had the highest ac-
tivity in matured cells, whereas HIF1A and c-MYC exhibited the
highest activity in proliferating cells (Fig. 8A). In contrast to the
prediction of its activation state, FOXO1 was highly active in ma-
tured cells.
Transcript levels of some selected genes were quantified in in-
dependent samples by qPCR (Fig. 8B). We selected a panel of
genes involved in cell cycle regulation [CDKN1A (p53 driven) and
CDC25A (c-MYC driven)], fatty acid metabolism (FASN and
BBOX1), transport (ATP1A1 and ATP1B1), and ciliogenesis
(BBS1). The gene cyclin-dependent kinase inhibitor 1A (CDKN1A;
the protein is also known as p21), which mediates the p53-depen-
dent cell cycle G1 phase arrest, was significantly more highly ex-
pressed only in the matured monolayer (day 16 after seeding). The
gene for cell division cycle 25A (CDC25A), which promotes the
transition from G1 to the S phase of the cell cycle and is a target of
c-MYC, exhibited an expression profile contrary to that of
CDKN1A and was highly expressed in the subconfluent and newly
confluent (day 1 and day 7 after seeding, respectively) monolayers,
which corresponded to the microarray data. The gene for fatty
acid synthase (FASN) exhibited reduced expression in the newly
confluent monolayer, whereas the transcript levels of the genes for
butyrobetaine (gamma), 2-oxoglutarate dioxygenase 1 (BBOX1),
a gene involved in L-carnitine synthesis, dramatically increased in
the newly confluent monolayer and further increased in the ma-
tured monolayer; the same expression trend was observed in the
microarray data. Expression of genes for the alpha and beta sub-
units (ATP1A1 and ATP1B1, respectively) of the Na/K ATPase
increased in the newly confluent monolayer, and high expression
was sustained in the matured monolayer, consistent with the mi-
croarray data. The gene for the protein Bardet-Biedl syndrome 1
(BBS1) is implicated in cilium function, and it exhibited aug-
mented transcript levels beginning in the newly confluent mono-
layer and continued to be highly expressed in the matured mono-
layer, as in the microarray data. The qPCR data for the selected
genes corresponded well to the microarray expression data.
Figure 9 summarizes the main results.
DISCUSSION
Both primary human renal proximal-tubule cells and the telom-
erase-expressing human proximal-tubule cell line RPTEC/TERT1
exhibited similar growth rates and similar timelines of transition
FIG 6 Functional grouping of genes exhibiting time-dependent expression during epithelial monolayer maturation. Genes were ranked within the allocated
group according to the difference between day 1 and 16 values in the RPTEC/TERT1 data set. Cell colors reflect the value and direction of the expression value
relative to the mean over all time points (red indicates higher expression and green indicates lower expression compared to the mean) (n 	 3). An asterisk
indicates that the group contains members that are shown in previous heat maps.
FIG 7 Predicted transcription factors (TFs) involved in the maturation process. Colors reflect the regulation z score and direction of regulation: yellow indicates
activation and blue indicates inhibition of the given TF. All TFs in this table had a P value of 0.001 for the overlap and a z score of 2 or 2 at at least one
time point in both cell models.
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from mesenchymal-type morphology to confluent monolayers
and ultimately dome-forming monolayers. Cadherins are integral
members of the adherens junctions that function as intercellular
adhesion molecules (28, 29). Here we observed an increase of
CDH1 (also known as E-cadherin) and CDH16 mRNA with a de-
crease in CDH4 mRNA over the maturation time. CDH1 protein
was expressed in high abundance at the cell-to-cell junctions
throughout the maturation process. CDH1 is pivotal for tissue
formation and forms homo-trans-interactions with neighboring
cells and homo-cis-interactions within its own cell plasma mem-
brane. The combination of trans and cis interactions promotes the
formation of a lattice-type adherens belt (30). CDH4 exhibited
sparse junctional localization at the early time points, but junc-
tional expression increased in the intermediate phase. Total pro-
tein expression was high at days 1 and 4 and decreased thereafter.
These findings support the role of CDH4 as a facilitator of cell
motility (31). CDH16 is a nonclassical cadherin lacking the histi-
dine-alanine-valine adhesion recognition sequence and is thought
to play a role in maintenance of terminally differentiated tubules
rather than initiation of renal morphogenesis (32). Here, CDH16
was absent in proliferating cells, but junctional expression in-
creased dramatically at confluence. In the matured epithelium,
there was a decrease in CDH16 total protein, and expression was
limited to the apices of cells in dome-forming regions. It has pre-
viously been shown that cells at the apices of domes are often
mitotic (33), and thus it is plausible that CDH16 plays a role in
maintenance of the epithelial barrier in dividing cells of the ma-
tured epithelium.
The expression of the claudin family of intercellular TJ pro-
teins determines the paracellular selectivity of different epithelial
FIG 8 (A) Activation levels of TFs TP53, FOXO1, c-MYC, and HIF1A in RPTEC/TERT1 nuclear extracts at days 1 and 16 after seeding. Values are means plus
SD (n 	 3). Statistical significance was analyzed by applying a two-tailed unpaired t test. *, P  0.05; **, P  0.01; ***, P  0.001. (B) qPCR of selected genes in
RPTEC/TERT1 cells at subconfluent (day 1 after seeding), newly confluent (day 7 after seeding), and matured (day 16 after seeding) time points. Values are
changes in copy number (fold) relative to biological replicate 1 on day 1. Values are means and SD (n 	 3). Statistical significance was analyzed using one-way
ANOVA with the Bonferroni multiple comparison test post hoc. *, P  0.05; **, P  0.01; ***, P  0.001.
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barriers (34). Here, the expression of genes for several claudin
subtypes increased during epithelial maturation, including
CLDN2 and CLDN10. These subtypes are highly expressed in the
human proximal tubule in vivo (35), and their pore-forming
properties are thought to be the reason for the relative leakiness of
this region compared to more distal segments (2, 36–38). We re-
cently demonstrated that oxidative stress decreases the expression
of CLDN2 and CLDN10 (39), which would support the notion
that cell injury can cause a reversal of the differentiation process
(40). Other members of the tight junction (TJ) complex, the
zonula occludens (ZO) protein family, act as sensors of epithelial
compactness and regulate proliferation through their interaction
with and sequestration of transcription modifiers (7, 12, 41–43).
In our transcriptomics data, genes involved in the cell cycle were
highly enriched at the early time points, and cell cycle analysis
showed that the majority of cells arrest in G0/G1 as soon as 5 days
after seeding. A small proportion of cell turnover remains there-
after. We observed an induction of TJP3 (also known as ZO3)
mRNA expression over time and a strong increase in protein lev-
els. Additionally, we could show that TJP3 is expressed in the
nucleus of proliferating cells, whereas cell-to-cell junction local-
ization was observed exclusively in the matured epithelium. Thus,
it is likely that TJP3 supports proliferation in subconfluent cells
but promotes cell cycle inhibition with increasing cell density, as
has been previously described for TJP1 (also known as ZO1) and
TJP2 (also known as ZO2) (44).
Proliferating cells require larger amounts of energy than non-
proliferating cells for biomass synthesis (nucleotides, proteins,
and membranes) (45). In our model, proliferating cells exhibited
an increased utilization of glucose and amino acids, including
FIG 9 Summary of key mechanisms and players in epithelial monolayer maturation. *, predicted transcription factor; #, expression confirmed using qPCR.
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glutamine, with a concomitant increased production of lactate
and formate. Matured monolayers also exhibited lower oxygen
consumption and lactate production rates, further indicating a
decreased energy requirement. However, we demonstrated
that their oxidative capacity was higher using the uncoupling
agent FCCP, and stereology analysis revealed a slightly increased
mitochondrial volume. In addition, transcript levels for peroxi-
some proliferator-activated receptor gamma, coactivator 1 alpha
(PPARGC1A), encoding a crucial factor for mitochondrial bio-
genesis (46) and fatty acid beta oxidation (47, 48), were increased
after confluence was reached. We also observed an increase in the
mRNA for the catalytic  subunit of pyruvate dehydrogenase
(PDHA1). In mitochondria, pyruvate dehydrogenase (PDH) con-
verts pyruvate to acetyl coenzyme A (acetyl-CoA), which is used as
a precursor for fatty acid synthesis or is fed into the TCA cycle
(49). In addition, genes involved in fatty acid synthesis were highly
expressed in proliferating cells, whereas genes implicated in beta-
oxidation were predominantly expressed in matured cells. We
have previously observed that exposure of differentiated renal and
hepatic cells to toxins increases lactate production (18), which is
likely due to impairment of mitochondrial oxidative respiration.
Thus, to establish whether low glycolysis rates in matured cells are
truly dependent on mitochondrial respiration, we measured gly-
colysis rates after exposure to the cytochrome c reductase inhibitor
antimycin A. Matured cells reverted back to glycolytic metabo-
lism, thus indicating that (i) their energy requirement is primarily
fulfilled by oxidative metabolism and (ii) they can switch to gly-
colysis when oxidative metabolism does not meet their energy
requirements.
The Na/K ATPase is the driving force of numerous second-
ary active transport processes generating an electrical and chemi-
cal gradient across the cell membrane (50). In the proximal tu-
bule, approximately 77% of the energy supplied by oxidative
metabolism is invested in the Na/K ATPase (3). This pump is
located on the basolateral membrane in most epithelial cells and
consists of a catalytic  subunit, a  subunit, and tissue-specific
FXYD proteins (51). FXYD2 is expressed in human fetal liver,
pancreas, and kidney (52), as well as in rat, pig, and dog kidneys,
but was not detected in several established renal cell lines (NRK-
52E, LLC-PK, and MDCK) (53). Here, the mRNA levels of the 1
(ATP1A1) and 1 (ATP1B1) subunits as well as FXYD2 were in-
creased at confluence and maintained at high levels. In contrast,
FXYD5 was highly expressed in proliferating cells (day 1) and
decreased on subsequent days. FXYD5 overexpression has previ-
ously been shown to decrease CDH1 and alpha catenin levels (26).
Thus, our data suggest that the expression of tissue-specific sub-
units of this pump is also promoted when the cells reach conflu-
ence.
Several genes involved in the cilium biogenesis and cilium
function exhibited increased expression over the maturation pro-
cess, including PCDP1, BBS1, and BBS12. Renal epithelial cells
contain a nonmotile primary cilium (14), which is thought to be
involved in the maintenance of tubular integrity and luminal fluid
sensing. Mounting evidence suggests a role for the deregulation of
specific cilia proteins in renal cystic disease, including polycystic
kidney disease and Bardet-Biedl syndrome (BBS) (54). BBS arises
due to mutations in one of the several BBS-encoding genes or
chaperones and has multiple nonrenal manifestations, although
renal dysfunction is the major cause of morbidity and mortality
(55). We recently demonstrated that carcinogen exposure can in-
duce the loss of primary cilia and that BBS1 is one of the genes
heavily attenuated by potassium bromate and ochratoxin A expo-
sure (56).
Utilizing the temporal alterations in the transcriptome, we per-
formed a transcription factor activation prediction using IPA. The
analysis revealed p53 (TP53) as the most active transcription fac-
tor in the matured epithelium, which was confirmed by quantify-
ing p53 TF activity. This highlights the central role of p53 in epi-
thelial maturation by promoting cell cycle arrest, oxidative
phosphorylation, and suppression of glycolysis, as has been shown
within different cellular contexts (57, 58). Other transcription fac-
tors that were predicted to be activated in the matured epithelium
included CDKN2A (p16) and retinoblastoma 1 (RB1). CDKN2A
disrupts cyclin D complexes (59), preventing cyclin D-mediated
retinoblastoma protein (RB) phosphorylation and causing G1 cell
cycle arrest (60). In addition, hypophosphorylated RB1 binds and
inhibits E2F transcription factors (61, 62). E2Fs have a central role
in mediating G1/S transition (63), and E2F1, -2, and -3 were pre-
dicted to be active during proliferation. The highest predicted
activity for transcription factors during proliferation was TBX2
(T-box 2). This transcription factor is overexpressed in several
cancers and promotes proliferation and metastasis by repressing
p14ARF (an alternating reading frame product of CDKN2A),
CDKN1A (also known as p21), N-myc downregulated gene 1
(NDRG1) and CDH1 (64). Additionally, c-MYC and HIF1A ex-
hibited higher transcriptional activity rates in proliferating cells.
Both transcription factors induce the transcription of pyruvate
dehydrogenase kinase 1 (PDK1) (65, 66), whose product phosphor-
ylates and inactivates PDH, thereby promoting glycolysis. Here,
PDHA1 mRNA was expressed at very low levels in highly prolif-
erating cells. FOXM1 (forkhead box M1) and FOXO1 (forkhead
box O1) were also predicted to be active in proliferating cells.
FOXM1 stimulates proliferation by regulating the genes involved
in G1/S, S, G2/M, and M cell cycle phase progression. It also trans-
activates MYC (67).
In contrast to its predicted activation state (early activation),
FOXO1 exhibited higher activity in the matured epithelium. The
FOXO family of TFs are tumor suppressors and have multiple
roles in cell cycle inhibition, apoptosis, cellular stress response,
and regulation of energy metabolism (68). The gene for insulin-
like growth factor binding protein 1 (IGFBP1), a target of FOXO1
(69, 70), is highly expressed during proliferation in the microarray
data set, consistent with the predicted activation. On the other
hand, some regulated FOXO1 targets involved in cell cycle inhi-
bition, like the CDKN1B protein (also known as p27) (71) and the
CDKN1C protein (also known as p57) (72), or in the regulation of
energy metabolism, like the PPARGC1A protein (73), are ex-
pressed at low levels in the subconfluent monolayer. Interestingly,
Nowak et al. (74) reported that expression of FOXO1 and FOXO3
was induced by E2F1, another predicted early activated TF. The
FOXO TFs have overlapping targets and activities, and their spec-
ificity depends on cell type, cellular context, and environmental
stimuli (75). FOXO1 is ubiquitously expressed but is highest in
insulin-responsive tissues, whereas FOXO3, which was predicted
in this study to be in the group of late-activated TFs, is primarily
expressed in kidney, brain, heart, and ovaries. Constitutively ex-
pression of FOXO1 in mouse liver resulted in the suppression of
de novo lipogenesis, upregulation of genes involved in gluconeo-
genesis and protein and amino acid catabolism, whereas genes
Aschauer et al.














































implicated in glycolysis, pentose phosphate shunt, and fatty acid
and sterol synthesis were downregulated (76).
In summary, this study provides an extensive unbiased charac-
terization of the transcriptional, metabolic, and functional altera-
tions during epithelial monolayer maturation of proximal tubular
epithelial cells (summarized in Fig. 9). We show that proliferating
cells have a higher energy demand with both increased glycolysis
and oxygen consumption and exhibit an immature cell-to-cell
junction complex with nuclear TJP3 expression and high activity
of HIF1A and c-MYC. The matured monolayers have lower en-
ergy demands, express TJP3, claudin 2, and claudin 10 at the in-
tercellular junctions, and exhibit high activities of p53 and
FOXO1. Given the main role for these processes in physiological
function and disease states such as cancer and fibrosis, these data
will be of great benefit in the further delineation of these complex
cellular pathways. Finally, these data will serve as a reference for
the development of differentiation strategies of inducible pluripo-
tent stem cells to a proximal-tubule phenotype.
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